Expression of numerous genes encoding myeloid-specific proteins is tightly regulated during normal myeloid differentiation. This heterogeneous group of genes thus offers a tool for dissection of different maturational steps of myelopoiesis. We have previously shown that the human myeloperoxidase (MPO) gene is modified at numerous CpG residues in normal myeloid cells and in myeloid cell lines in a development-specific and expression-associated manner. In the present work, we have applied this type of methylation analysis to primary leukemia myeloid cell samples. We found that expression of MPO messenger RNA (mRNA) is grossly URING THE intermediate and late stages of myeloid D differentiation, numerous genes are expressed that encode proteins germane to the specific functions of mature myeloid cells.' Acute myeloid leukemia (AML) is characterized by a block in differentiation of myeloid cells toward functional, end-stage hematopoietic cells. This maturational arrest can occur at various stages of differentiation. Myeloperoxidase (MPO) is the most abundant protein in primary (azurophilic) granules of myeloid cell^.^,^ Thus, detection of this protein traditionally has been an important tool in cytochemical analysis of myeloid leukemias. In a previous study, we examined gene expression of the MPO gene as it relates to different maturational stages of myeloid cells (exemplified by cell lines established for continuous growth in ~u l t u r e ) .~.~ We found that expression of the MPO gene is restricted to the late myeloblastic and the promyelocytic stages of differentiation. At earlier stages, the gene is not expressed; at later stages, transcription is downregulated.436 However, chromatin structural ana lyse^^.^ and examination of the DNA methylation of the MPO genes have shown that at earlier stages, this gene locus already has undergone changes that presumably left it poised for gene transcription at a later stage. In the previous study, different normal blood cells, as well as myeloid cell lines, were used. Recently, it has become clear that cultured cells passaged over a period of time frequently exhibit modifications of the methylation patterns that differ from those seen in primary cell^.^^^ Remethylation of genes that are nones- sential for survival and proliferation in vitro may serve as an adaptation step to culture conditions. In the present study, we have tested the hypothesis that distinct, expression-dependent and -independent demethylating events in the MPO gene have occurred in a stepwise manner in different subtypes of AMLs. Using cells from a large number of primary, uncultured AMLs, we confirm and extend our previous findings by showing that expression of MPO is restricted to the more mature myeloblastic and the promyelocytic subtypes of AML. In immature MPOnonexpressing myeloblastic leukemias, demethylation was present only in the 3' region of the gene; in MPO-expressing myeloblastic and promyelocytic leukemias, a switch toward demethylation in the 5' region had occurred. This demodification did not occur globally in the genome of more mature myeloid cells; also, it was not coupled to phorbol esterinduced, low-level expression of MPO.
D differentiation, numerous genes are expressed that encode proteins germane to the specific functions of mature myeloid cells.' Acute myeloid leukemia (AML) is characterized by a block in differentiation of myeloid cells toward functional, end-stage hematopoietic cells. This maturational arrest can occur at various stages of differentiation. Myeloperoxidase (MPO) is the most abundant protein in primary (azurophilic) granules of myeloid cell^.^,^ Thus, detection of this protein traditionally has been an important tool in cytochemical analysis of myeloid leukemias. In a previous study, we examined gene expression of the MPO gene as it relates to different maturational stages of myeloid cells (exemplified by cell lines established for continuous growth in ~u l t u r e ) .~.~ We found that expression of the MPO gene is restricted to the late myeloblastic and the promyelocytic stages of differentiation. At earlier stages, the gene is not expressed; at later stages, transcription is downregulated.436 However, chromatin structural ana lyse^^.^ and examination of the DNA methylation of the MPO genes have shown that at earlier stages, this gene locus already has undergone changes that presumably left it poised for gene transcription at a later stage. In the previous study, different normal blood cells, as well as myeloid cell lines, were used. Recently, it has become clear that cultured cells passaged over a period of time frequently exhibit modifications of the methylation patterns that differ from those seen in primary cell^.^^^ Remethylation of genes that are nones-sential for survival and proliferation in vitro may serve as an adaptation step to culture conditions.
In the present study, we have tested the hypothesis that distinct, expression-dependent and -independent demethylating events in the MPO gene have occurred in a stepwise manner in different subtypes of AMLs. Using cells from a large number of primary, uncultured AMLs, we confirm and extend our previous findings by showing that expression of MPO is restricted to the more mature myeloblastic and the promyelocytic subtypes of AML. In immature MPOnonexpressing myeloblastic leukemias, demethylation was present only in the 3' region of the gene; in MPO-expressing myeloblastic and promyelocytic leukemias, a switch toward demethylation in the 5' region had occurred. This demodification did not occur globally in the genome of more mature myeloid cells; also, it was not coupled to phorbol esterinduced, low-level expression of MPO.
MATERIALS AND METHODS

Cells.
After receiving informed consent, heparinized venous blood or bone marrow samples were obtained from patients with different types of AML. Diagnoses were made according to the French-American-British (FAB) classification.1° Samples were evaluated by three independent investigators (members of the German Multicenter AML Study Group). In addition, cells were characterized by immunohistochemistry using a panel of monoclonal antibodies directed against various myeloid-and lymphoidassociated surface markers. Mononuclear cells were isolated by Ficoll-hypaque density separation," washed several times with phosphate-buffered saline (PBS), and processed for nucleic acids analyses. Cell preparations consisted of greater than 85% leukemic cells as judged by inspection. Promyelocytic HL-60 cells and cells from a patient with acute undifferentiated leukemiaI2 were cultured in RPMI medium supplemented with 10% fetal calf serum at 37°C in a 7% C02 atmosphere.
DNA clones. A 405-bp Sma IISma I restriction fragment (Sma-C; complementary to exons 3 to 5 of MPO) and a 1,123-bp Sma I/ Sma I fragment (Sma-B; encompassing MPO exons 7 to 12) were excised from the human MPO cDNA clone pMP02 (kindly provided by Phillip Koeffler, Cedars Sinai, Los Angeles).13 The 414-bp Pst IIPst I fragment complementary to part of exon 2 of MYC was excised from the pHSRI p1a~mid.I~ A 730-bp DNA fragment was used to detect the constant region of the human T-cell receptor (TCR) a-chain. 15 The approximately 800-bp BamHI1 Pst I fragment of a-actin cDNAI6 was used as control on Northern blots. DNA was isolated by the method of Chirgwin et al," purified by digestion DNA isolation and methylation analysis by Southem blot. For methylation analysis by endonuclease restriction, several modifications of specifications provided by the manufacturers were used to ensure completeness of digestion: (1) 50 pg of high molecular weight genomic DNA was initially digested in a large reaction volume with a fivefold excess of Hind111 (Boehringer Mannheim, Mannheim, Germany) for 16 hours; cleaved DNA was precipitated and redissolved in TE at a final concentration of 1 to 1.5 pg/pL; (2) preparations of Hindlll-digested DNA were additionally digested with Sma I (Boehringer Mannheim) or Xma I (New England Biolabs. Beverley, MA); restrictions were performed with 10-fold and twofold excess of enzyme, respectively (U enzymelpg DNA); (3) after 6 hours, more enzyme was added to a final concentration of 20 and 4 U/pg DNA, respectively, and digested for an additional 12 hours; (4) to a sister reaction, I pg of A-phage DNA was added and completeness of digestion was checked on agarose gel.
Restricted DNA was size-fractionated on Tris-acetate agarose gels and transferred to nylon-based filter membrane (Genescreen Plus; Dupont de Nemours. Wilmington, DE) with 10x SSC (1 x SSC = 0.15 mol/L NaCI, 0.015 mol/L sodium tricitrate; pH 7.0) by capillary force for 16 hours. After completion of transfer, membrane-bound DNA was denatured by soaking of membrane in 0.4 mol/L NaOH for 1 minute, filter was rinsed in 0.2 mol/L Tris, pH 7 . 4 / 2~ SSC, and air-dried. Hybridization with 32P-oligolabeled'x probes was performed at 42°C for 16 to 36 hours in the presence of 50% formamide, 10% dextran sulfate, 1% SDS. 4 x Denhardt's solution, and 5 x SSPE ( 1 x SSPE = 0.18 mol/L NaCI, 10 mmol/L sodium phosphate, 1 mmol/L EDTA), and 3 to 4 X IW' cpm of probe labeled to high specific activity and denatured in 200 WL of sheared salmon sperm DNA (10 mg/mL) by boiling. Filters were rinsed in decreasing concentrations of SSC to a final stringency of 0 . 2 5~ SSC at 65°C for 15 minutes and exposed with Kodak X-AR 5 film (Eastman Kodak, Rochester, NY) at -70°C in the presence of an intensifying screen (Dupont de Nemours). Even at this high stringency, some cross-hybridization to the eosinophil peroxidase gene, which in several portions of its coding region has a high degree of homology to MPO gene,19 was observed in some Southern blot experiments.
Total cellular RNA was extracted from leukemic cells and cell lines.'' RNA was dissolved in TES (10 mmol/LTris 7.4, 1 mmol/L EDTA, 0.1% SDS), RNA isolarion and Northern hlor analysis. 
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LOBBERT ET AL electrophoresed on denaturing formaldehyde-agarose gels, and transferred to nylon-based filter membrane (Nytran; Schleicher & Schuell, Dassel, Germany). Filters were baked for 2 hours at 80°C and hybridized at 42°C for 16 hours under conditions described previou~ly.~ Filters were rinsed at 65°C to a final stringency of 0 . 1~ SSC and autoradiographed at -70°C using intensifying screens. Inspection of ethidium-bromide-stained gels and rehybridization with a probe for a-actin sewed as indicators for integrity and equal loading of RNA. For Fig 2) . Southcrn blot analysis with a MPO DNA probc complementary to cxons 3 to 5 results in a 19-kb Hind111 fragmcnt spanning thc entire coding region. as wcll as 2 kb immcdiatcly 5' of cxon 1 and 6 kb 3' of cxon 12.'"3 Doublc-digcstion with Hind111 and Xma I rcsults in a singlc fragmcnt of 3.3 kb as a rcsult of clcavagc at a Sma IIXtna I sitc within thc CpG-rich island of thc M P O gcnc (sitc a in Fig 2) . Thc range of bands sizing bctwccn 19 kb and 3.3 kb thus indicatcs thc dcgrcc to which dcmethylation of thc MPO gcnc will bc dctcctcd whcn doublc-digcsting with Hind111 and Smn 1. Thcsc bands can casily bc mappcd by virtuc of the 5' localization of thc S-C probc ("indircct end-labcling"). In addition, usc of the 3' specific probc (S-B) yicldcd information in C~S C S whcrc complctc dcmcthylation had occurrcd at sitcsa and h in thc 5 . thc dcgrcc of dcmcthylation was quitc variablc bctwccn diffcrcnt patients, ranging from SOr+ or lcss dcmcthylation cxclusivcly at the most 3' sitc (c). to complctc dcmcthylation at all fivc sitcs. The data thus gcncratcd for 25 paticnts werc plotted aftcr visual inspcction of thc rclativc band intcnsitics of thc Southcrn blots; thcy arc summarizcd in Tablc 2 and show a striking association bctwccn cxprcssion of thc MPO gcnc and dcmcthylation at sitcs a, h, and c . Howevcr, t h i g association was only obscrvcd in paticnts with acutc mycloblastic and promyclocytic lcukcmias (MI-3). but not in lcukcmias with myclomonocytic or monoblastic fcaturcs (M4 and MS).
RESULTS
Expression of
Differential metlylotion in the MPO gene of difirent ype.7 of myeloid Ieitkemic cells i.s not dire to global methylation differences between these cel1.Y. To rulc out global mcthylation diffcrcnccs as a cause of thc diffcrcntial mcthylation obscrvcd in thc MPO gcnc of thc AML paticnts studicd. DNAs analyzed by Southcrn blot and with mcthylationscnsitivc and -inscnsitivc rcstriction cnzymcs wcrc scqucntially probcd for gcncs on othcr chromosomcs that arc rcgulatcd in a manncr that is diffcrcnt from MPO (locatcd on thc long arm of chromosomc 17). Spccifically, wc chosc a gcnc whosc cxprcssion is gcrmanc to the T-ccll lincagc and thus only vcry rarely detcctcd in AML cclls, ic. the constant rcgion of TCR-a (locatcd on chromosomc 14: ncgativc cxprcssion data not shown), and a housckccping gcnc that is ubiquitously cxprcsscd in a varicty of diffcrcnt cell types, ic, MYC (locatcd on chromosomc 8). According to a modcl of diffcrcntial mcthylation in tissuc-spccific gcncs but not in ubiquitously cxprcsscd gcncs,'? onc would predict (1) expression-dependent demethylation in the lineage-specific gene, (2) a high degree of methylation in the nonexpressed gene locus regulated in a tissue-specific manner but germane to a different cell lineage, and (3) an invariant methylation pattern in the ubiquitously expressed gene. As shown in Fig 4, the portion of the TCR-a constant region probed for was in germline configuration in the leukemic cells and was completely and invariantly methylated in all cases studied (Fig 4B) . In contrast, the MYC gene was completely and invariantly demethylated in each case (Fig   Induction of low-level erpression of MPO mRNA is not associated with methylation changes. To examine whether induction of MPO expression is associated with methylation changes in this gene, primary cells from a patient with acute undifferentiated leukemia (AUL) were analyzed. Upon culturing with 12-0-tetradecanoyl phorbol-13-acetate (TPA) for 3 days, these cells underwent drastic morphological changes, and more than 80% of cells adhered to the plastic wall of the tissue culture flask. Ultrastructural peroxidase activity has been detected in the phorbol ester-treated cells, but not in the untreated cells.t2 By Northern blot analysis, MPO transcripts were not detected in untreated cells (Fig 5A) , even after deliberate overexposure of the filter. In contrast, MPO transcripts were detectable in 4C).
TPA-treated cells, albeit at levels at least 50-fold lower than those observed in HL-60 (note that 20 pg of total RNA was loaded in lanes 1 and 2, and 2 pg in lane 3). Methylation analysis was performed on DNA from these cells before and after culturing with TPA. Untreated cells exhibited a pattern of approximately 25% demethylation at the Sma I site e located within MPO exon 12, as indicated by an approximate 3:l ratio of the 20-kb and 14-kb bands in a HindIIIISma I digest (Fig 5B) . In the TPA-treated, MPOexpressing cells, this ratio did not change significantly.
DISCUSSION
The features of immature white blood cells as observed during the maturational arrest in acute myeloid leukemias are commonly defined by morphological, cytochemical, immunological, and, more recently, cytogenetic criteria.l0 Analysis of mRNA expression of genes regulated during myeloid maturation may yield an additional tool for dissecting these developmental stages.' In the present study, we investigated the relationship between DNA demodification of cytidine nucleotides bearing methyl moieties of the human MPO gene (demethylation), subsequent expression of its mRNA, and the phenotype of primary AML cells. 2; -, Sma I site is 90% to 100% methylated; +, Sma I site is 50% to 90% methylated; f, Sma I site is 10% to 50% methylated; +, Sma I site is 0% to 10% methylated.
Expression of this gene in normal myeloid precursor cells of
human bone marrow is confined to late myeloblasts and to promyelocyte~.~~ We confirm that mRNA expression of this gene is grossly restricted to AML cells of M2 and M3 s~b t y p e s .~~,~ This is in line with MPO expression data obtained with different myeloid cell lines. 4 Demethylation has been observed in numerous genes and often correlates with their expression, particularly with tissue-specific genes.22,26-27 Thus, this process is probably involved in some way in the regulation of gene expression. However, its exact role in transcriptional control and the mechanisms by which the demodification is brought about are far from clear. Particularly, it is unclear whether it is causally involved in transcription or is an epiphenomenon, and whether demethylation is an active or passive process.
The MPO gene is very tightly regulated in a tissue-and development-specific manner.4 Therefore, we chose this gene as a model in a study designed to address the possible role of methylation differences in myeloid leukemic cells of different degrees of immaturity.
Evaluation of the methylation status of Sma I restriction sites within this gene was of particular interest, because two sites are part of its CpG-rich island and thus located very close to a region bearing several features of a transcriptional enhancer element.7,20 We have previously shown that multiple restriction sites within this island behave similarly with regard to their methylation statu^.^ This observation has also been made in other CpG-rich islands using genomic s e q~e n c i n g ? ,~~-~~ Thus, evaluation of the two Sma I sites within the CpG-rich island by inference should yield information about the methylation status of the island.
The observed changes of a switch toward demethylation in the MPO gene occurring during turning-on of its transcription are complex. In all samples, even in very immature, MPO-nonexpressing cells, there was at least partial demethylation at the Sma I site within exon 12 ("e"). Demodification of this site is thus independent of MPO expression and of the degree of myeloid maturation exhibited by these cells. In contrast, demethylation at Sma I sites a and b (both part of the CpG-rich island) was strictly associated with expression of MPO in cells of the myelocytic lineage.
Interestingly, this correlation was not observed in cells with myelomonocytic and monoblastic features, in which both sites were frequently demethylated despite lack of MPO expression. other^,^^,^^ as well as 0urselves,5,~~ have shown that shut-off of gene expression of numerous genes with terminal differentiation of hematopoietic cells can be associated with the persistence of a pattern of stable and often complete demethylation of these genes. Thus, it is tempting to speculate that a subset of leukemic cells with myelomonocytic and monoblastic features carries the demethylated state of the MPO gene region, which conceivably would allow transcription of this gene; however, these cells might lack other components of the transcriptional apparatus that are necessary for active transcription of the gene. Nuclear run-off experiments have shown that in early myeloblastic KG-1 cells, which exhibit a high degree of methylation, the MPO gene is not actively transcribed (unpublished observation). However, as shown here, phorbo1 ester-induced low-level MPO expression in very immature leukemic cells is not accompanied by significant changes toward demethylation. Therefore, it appears that demethylation by itself is not necessary for (induced) MPO expression. Also, our results suggest that a block in differentiation as exemplified by a high degree of methylation is only partially overcome by induction of differentiation through differentiation-inducing compounds. However, this result also implies that the imprint onto the primary DNA sequence imparted by methylation can be quite staple and can remain unmodified despite the numeroes changes induced by the phorbol ester.
A study has shown that, using in vitro models, demethylation of certain gene regions is necessary for an "open" chromatin structure,34 and that demethylation of certain sites can facilitate that of other sites in cis.35, 36 The stepwise demethylation described here would fit into a model where 3' demethylation is a very early event in the differentiation pathway, with subsequent demethylation during further maturation and switching-on of gene expression. It has been proposed that chromosomal localization may be an important prerequisite for establishment of a specific DNA methylation pattern.37 Preliminary data on the methylation status of the G-CSF gene (also located on the long arm of For personal use only. on October 30, 2017 . by guest www.bloodjournal.org From chromosome 17 [17q21])38,39 suggest that in AMLs, this gene is demodified in a manner similar t o MPO (chromosomal location 17q23).40 However, the observed methylation differences between different leukemias clearly are not due to global differences in the degree of DNA modification. Invariant methylation patterns were observed in MYC (expressed in the manner of a housekeeping gene)33 and TCR-a. TCR genes have previously been shown to be differentially methylated with differential expression in lymphoid ~e l l s .~l -~~
In conclusion, examination of the primary gene structure of MPO (and possibly also other myeloid-specific genes regulated in a similarly tight manner) might be useful for determining very early and late developmental stages during which mRNA expression of such genes has either not yet occurred or has ceased. Thus, this type of methylation analysis might yield novel molecular indicators in myeloblastic leukemias for different early stages of myeloid maturation.
